SCHEMBL11114436

SCHEMBL11114436

C=CCOc1ccccc1OCCNCC(O)C[O]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 10/20 0.51
ADRB1 P08588 4/20 0.51
HTR1A P08908 2/20 0.51
SLC22A1 O15245 1/20 0.51
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
HTR2A P28223 1/20 0.51
SLC6A4 P31645 1/20 0.51
ADRA1A P35348 1/20 0.51
KDM4E B2RXH2 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALDH1A1 P00352 2/20 0.44
ADRB3 P13945 1/20 0.44
LIG1 P18858 1/20 0.44
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11809319 0.81 ADRB2 (0.71) ADRB2ADRB1HTR1ASLC22A1LMNA
SCHEMBL8972933 0.76 ADRB2 (0.68) ADRB2ADRB1HTR1ASLC22A1LMNA
Hydrochloric Acid SCHEMBL11263040 0.76 ADRB2 (0.54) ADRB2ADRB1HTR1ASLC22A1LMNA
SCHEMBL10756505 0.75 DRD2 (0.56) ADRB2ADRB1HTR1ASLC22A1LMNA
SCHEMBL11554807 0.75 ADRB2 (0.56) ADRB2ADRB1HTR1ASLC22A1LMNA
SCHEMBL11150348 0.73 TSHR (0.61) ADRB2ADRB1HTR1AADRA1ASMN1; SMN2
SCHEMBL10716946 0.73 ADRB2 (0.56) ADRB2ADRB1HTR1ASLC22A1LMNA
1,2-Diallyloxybenzene SCHEMBL29768784 0.71 HPGD (0.60) ADRB2ADRB1HTR1ASLC22A1LMNA
1,2-Diallyloxybenzene SCHEMBL366516 0.71 HPGD (0.60) ADRB2ADRB1HTR1ASLC22A1LMNA
SCHEMBL7924927 0.70 HPGD (0.57) ADRB2ADRB1HTR1ASLC22A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0121176-A1 Indolinone-2 derivatives, process for their preparation, medicines containing them and intermediate compounds Roche Diagnostics GmbH (DE) 1984-10-10 EP disclosed